Featured News

The following study, which examines the prevalence of dermatitis herpetiformis (DH), was made possible by the Foundation’s iCureCeliac® patient registry.

New research from Columbia University revealed differences in the antibodies present, adding evidence that NCGS involves a different kind of inflammation in the gut in response to gluten.

The first study of its kind in North America has found an increased risk for birth defects in children of women with active, untreated celiac disease.

The Celiac Disease Foundation is proud to partner with Mediaplanet for their Morning Nutrition campaign.

The Celiac Disease Foundation is pleased to have partnered with the Columbia University Celiac Disease Center and Farncombe Family Digestive Health Research Institute at McMaster University Medical Center to recruit patients for an international study that found those with celiac disease are not at an increased risk of contracting COVID-19. 

Three-time Guinness World Record holder & founder of the inaugural NY Turkey Trot, Craig Pinto, kicks to raise funds for a cure & achieves his fourth Record.

The Foundation is pleased to announce its partnership with Provention Bio to provide clinical trial recruitment for its Phase 2b PROACTIVE Celiac Study for PRV-015 (an anti-interleukin-15 monoclonal antibody).

A new study from Columbia University is the first to follow the trail for many years and show that people diagnosed with celiac disease in childhood are more likely to experience psychological conditions well into adulthood.

Securing public and private health insurance coverage of Medical Nutrition Therapy (MNT) for celiac disease patients has been a long-time priority of the Celiac Disease Foundation.

The Celiac Disease Foundation through the generosity of Proud Sponsor Schar is providing reimbursement grants to dietitians who complete all five COT modules.